Information Provided By:
Fly News Breaks for May 19, 2017
May 19, 2017 | 08:17 EDT
Jefferies analyst Brian Tanquilut says that while McKesson's FY18 guidance came in above consensus on the surface, a deeper look suggests that absent a $200M deferred revenue adjustment for Change Healthcare and a lower tax rate, the apples-to-apples comparison was an earnings per share outlook of $10.81-$11.51 versus the $11.45 consensus. On an apples-to-apples basis, the earnings guidance is below consensus, Tanquilut tells investors in a post-earnings research note. He keeps a Hold rating on McKesson. The stock in premarket trading is up 8% to $153.00.
News For MCK From the Last 2 Days
May 23, 2017 | 10:21 EDT
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. McKesson (MCK) upgraded to Overweight from Neutral at JPMorgan with analyst Lisa Gill saying she believes additional value should be unlocked from the Change transaction and that the valuation discount versus peers is unwarranted. 2. Aegion (AEGN) upgraded to Buy from Hold at Craig-Hallum with analyst Eric Stine saying the recent pullback provides an attractive opportunity to own a "high-quality company" with positive trends across much of its business. 3. Wingstop (WING) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Karen Holthouse saying there is upside to her $36 price target. Holthouse believes Wingstop is well positioned for digital ordering and off-premise tailwinds and expects an acceleration in same-store-sales driven by national advertising momentum. 4. Parexel (PRXL) upgraded to Neutral from Sell at Goldman Sachs with analyst Robert Jones citing reduced consensus expectations and industry consolidation. 5. On Deck Capital (ONDK) upgraded to Outperform from Market Perform at FBR Capital with analyst Bob Ramsey saying he believes the company's path to profitability creates "significant" upside for the shares over the next 12 months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
May 23, 2017 | 06:30 EDT
JPMorgan analyst Lisa Gill upgraded McKesson to Overweight and raised her price target for the shares to $189 from $167. The analyst believes additional value should be unlocked from the Change transaction and that the valuation discount versus peers is unwarranted.
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.